Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)

Clinical trial NCT03493945 · COMPLETED

Trial details

NCT number: NCT03493945
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer Prostate Cancer Prostate Neoplasm Advanced Solid Tumor Solid Tumor Non-metastatic Castration-resistant Prostate Cancer

Start date: 2018-05-01
Primary completion: 2024-10-08
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.